Scientists have discovered a significant difference in the immune systems of individuals that may explain variations in health as people age. While young people have many naive T cells, exposure to pathogens and vaccines gradually converts these into memory cells that can respond swiftly to infections.
Recent research published in Immunity focused on granzyme K and granzyme B, two types of proteins made by memory cells responsible for controlling infected cells. The study revealed that a higher presence of granzyme K-producing cells, relative to granzyme B-producing cells, is associated with healthier aging.
The research analyzed blood samples from over 2,600 participants aged 18 to 97, identifying individuals with an unfavorable ratio of granzyme K to B as more susceptible to autoimmune diseases and chronic conditions. A follow-up investigation in the UK Biobank also showed that individuals predicted to have higher levels of granzyme B had worse health outcomes, including increased risks of diabetes, high blood pressure, and mortality.
The implications of this research suggest that the granzyme K-to-B ratio could serve as a biomarker for aging health trajectories. However, further studies are necessary to determine if this balance directly influences health outcomes or if it merely correlates with them, as the distinctions between immune responses in mice and humans could complicate interpretations. Overall, this ratio may provide valuable insights into the biology of aging and immunity.
